Alto Neuroscience Statistics Share Statistics Alto Neuroscience has 27.07M
shares outstanding. The number of shares has increased by 0.42%
in one year.
Shares Outstanding 27.07M Shares Change (YoY) 0.42% Shares Change (QoQ) 0% Owned by Institutions (%) 76.2% Shares Floating 21.49M Failed to Deliver (FTD) Shares 3,097 FTD / Avg. Volume 1.28%
Short Selling Information The latest short interest is 2.05M, so 7.57% of the outstanding
shares have been sold short.
Short Interest 2.05M Short % of Shares Out 7.57% Short % of Float 9.61% Short Ratio (days to cover) 15.68
Valuation Ratios The PE ratio is -1.69 and the forward
PE ratio is -1.11.
Alto Neuroscience's PEG ratio is
-0.02.
PE Ratio -1.69 Forward PE -1.11 PS Ratio 0 Forward PS n/a PB Ratio 0.69 P/FCF Ratio -2.1 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alto Neuroscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 16.92,
with a Debt / Equity ratio of 0.11.
Current Ratio 16.92 Quick Ratio 16.92 Debt / Equity 0.11 Debt / EBITDA -0.25 Debt / FCF -0.34 Interest Coverage 49.9
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-808.3K Employee Count 76 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -62.77% in the
last 52 weeks. The beta is 1.85, so Alto Neuroscience's
price volatility has been higher than the market average.
Beta 1.85 52-Week Price Change -62.77% 50-Day Moving Average 2.64 200-Day Moving Average 3.34 Relative Strength Index (RSI) 64.2 Average Volume (20 Days) 241,453
Income Statement
Revenue n/a Gross Profit n/a Operating Income -68.61M Net Income -61.43M EBITDA -68.61M EBIT -62.81M Earnings Per Share (EPS) -2.5
Full Income Statement Balance Sheet The company has 168.23M in cash and 16.94M in
debt, giving a net cash position of 151.28M.
Cash & Cash Equivalents 168.23M Total Debt 16.94M Net Cash 151.28M Retained Earnings -138.4M Total Assets 171.91M Working Capital 156.27M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -47.42M
and capital expenditures -2.08M, giving a free cash flow of -49.5M.
Operating Cash Flow -47.42M Capital Expenditures -2.08M Free Cash Flow -49.5M FCF Per Share -2.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
